Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
594 BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.